Global Omega 3 Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com
Global Omega 3 Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Omega 3 Market Size, Share & Trends Analysis Report by Type (EPA, DHA), by Source (Marine, Plant), by Application (Supplements & Functional Foods, Infant Formula), by Region (APAC, CSA), and Segment Forecasts, 2020 - 2028" report has been added to ResearchAndMarkets.com's offering.
都柏林--(美國商業新聞網)--《2020-2028年歐米茄3市場規模、份額和趨勢分析報告》增加了按類型(EPA、DHA)、來源(海洋、植物)、應用(補充劑和功能食品、嬰兒配方奶粉)、地區(APAC、CSA)和細分市場預測的報告Research andMarkets.com的獻祭。
The global omega 3 market size is expected to reach USD 3.82 billion by 2028, registering a CAGR of 7.8% over the forecast period. DHA and EPA can help improve brain health in children and heart health in adults, which is likely to boost the market growth. The rising scope of applications of omega 3 in pharmaceuticals is also supporting product consumption. Players are focusing on offering high-quality pharma-grade omega 3. For instance, FMC Corp.'s Epax brand offers concentrated marine omega-3 fatty acids sourced from sustainable and traceable raw materials and caters to the requirements of high-quality pharmaceutical ingredients.
預計到2028年，全球歐米茄3市場規模將達到38.2億美元，在預測期內實現7.8%的複合年增長率。DHA和EPA可以幫助改善兒童的大腦健康和成年人的心臟健康，這可能會推動市場增長。Omega 3在製藥領域的應用範圍不斷擴大，也在支持產品消費。玩家正專注於提供高質量的藥用級omega 3。例如，FMC Corp.的Epax品牌提供濃縮的海洋omega-3脂肪酸，這些脂肪酸來自可持續和可追溯的原材料，並迎合了高質量藥物成分的要求。
The global market is characterized by the presence of prominent players, such as BASF SE, Koninklijke DSM N.V., Lonza, and Croda International Plc, which is expected to increase the competition. Players are focusing on catering to specific client requirements to widen the customer base.
全球市場的特點是出現了著名的參與者，如巴斯夫SE、Koninklijke DSM N.V.、Lonza和Croda International Plc，預計這將加劇競爭。玩家正專注於迎合特定的客户需求，以擴大客户基礎。
For instance, Crius Life Sciences have the formulation capacity of producing EPA/DHA with concentration level according to the client needs, such functionality offers a higher degree of freedom. Companies are utilizing krill oil as an alternative source to fish oil due to rising levels of contamination in fish oil. For instance, in November 2019, Aker BioMarine and Acasti Pharma signed a krill oil supply agreement to develop an innovative hypertriglyceridemia drug, using krill oil as its core ingredient.
例如，Crius生命科學具有根據客户需求生產濃度水平的EPA/DHA的配方能力，這種功能提供了更高的自由度。由於魚油的污染水平不斷上升，公司正在利用磷蝦油作為魚油的替代來源。例如，2019年11月，Aker BioMarine和Acasti Pharma簽署了一項磷蝦油供應協議，以開發一種使用磷蝦油作為核心成分的創新高甘油三酯血癥藥物。
Companies Mentioned
提到的公司
- Aker Biomarine Antarctic As
- Basf Se
- Bioprocess Algae, Llc
- Croda International Plc
- Epax
- Gc Reiber Oils
- Koninklijke Dsm N.V.
- Lonza
- Omega Protein Corporation.
- Orkla Health (Axellus)
- Aker Biomarine南極AS
- 巴斯夫Se
- 生物處理藻類有限責任公司
- 克羅達國際公司
- Epax
- GC雷伯油
- Koninklijke DSM N.V.
- 龍沙
- 歐米茄蛋白質公司。
- Orkla Health(Axellus)
Omega 3 Market Report Highlights
歐米茄3市場報告要點
- Eicosapentaenoic Acid (EPA) held a revenue share of 25.3% in 2020 and is expected to grow rapidly over the forecast period owing to the rising demand from the pharmaceutical industry
- For instance, BASF SE offers Maxomega EPA 97 EE eicosapentaenoic acid ethyl ester that can be used in Japanese "Epadel", and American "Vascepa" drugs for its benefits in cardiovascular health
- Manufacturers focus more on new product development to strengthen their market presence. For instance, in November 2019, BASF launched Hepacor, which contains highly concentrated purified EPA and DHA, for the dietary management of Non-Alcoholic Fatty Liver Disease (NAFLD)
- The marine source segment is expected to register the fastest CAGR of 8.1% over the forecast period owing to the rising production of omega 3 from non-fish-based marine sources, such as krill and algal oils
- Algal oil is gaining popularity among vegan consumers as it does not contain traces of fish oil or fishy odor
- Companies are exploring alternative sources to marine species owing to the rising adoption of plant-based products globally
- For instance, in August 2019, Cargill received approval for producing omega 3 sourced from canola, which can be widely used in the aquaculture feed industry
- The infant formula segment is expected to grow at the fastest CAGR over the forecast period owing to the rising awareness about infant nutrition
- Growing consumption of breast milk substitutes, which closely resemble the functionality and composition of breast milk, is also anticipated to drive the infant formula segment
- 二十碳五烯酸(EPA)在2020年的收入份額為25.3%，由於製藥行業的需求上升，預計在預測期內將快速增長
- 例如，巴斯夫SE提供Maxomega EPA 97EE二十碳五烯酸乙酯，可以用於日本的Epadel，以及美國的Vascepa藥物，因為它對心血管健康有好處
- 製造商更注重新產品的開發，以加強他們的市場佔有率。例如，2019年11月，巴斯夫推出了Hephacor，它含有高度濃縮的精製EPA和DHA，用於非酒精性脂肪性肝病(NAFLD)的飲食管理
- 由於磷蝦和藻油等非魚類來源的omega 3產量增加，預計海洋來源部分在預測期內將錄得8.1%的最快複合年增長率。
- 海藻油在素食消費者中越來越受歡迎，因為它不含微量魚油或魚腥味
- 由於全球越來越多地採用植物性產品，公司正在探索海洋物種的替代來源
- 例如，2019年8月，嘉吉獲得批准，可以生產從油菜籽中提取的omega 3，可廣泛用於水產養殖飼料行業
- 由於人們對嬰兒營養的認識不斷提高，預計嬰兒配方奶粉市場在預測期內將以最快的複合年增長率增長。
- 與母乳的功能和組成非常相似的母乳替代品的消費不斷增長，預計也將推動嬰兒配方奶粉細分市場
Key Topics Covered:
涵蓋的主要主題：
Chapter 1. Methodology and Scope
第一章方法和範圍
Chapter 2. Executive Summary
第2章.執行摘要
Chapter 3. Omega 3 Market: Variables, Trends & Scope
第三章歐米茄3市場：變量、趨勢和範圍
3.1. Market Lineage Outlook
3.1.市場譜系展望
3.2. Penetration & Growth Prospect Mapping
3.2.滲透率與增長前景圖
3.3. Value Chain Analysis
3.3.價值鏈分析
3.4. Omega-3 Analysis
3.4.Omega-3分析
3.4.1. New Products
3.4.1。新產品
3.5. Technology Overview
3.5.技術概述
3.5.1. Technology Trends
3.5.1。技術趨勢
3.5.1.1. Omega-3
3.5.1.1。歐米茄-3
3.5.1.2. Krill Oil
3.5.1.2。磷蝦油
3.5.1.2.1. Multi Stage Oil Extraction
3.5.1.2.1。多級採油
3.6. Regulatory Framework
3.6.監管框架
3.6.1. Product Classification Codes
3.6.1.產品分類編碼
3.6.2. Standards Andcompliances
3.6.2.標準和合規性
3.6.3. Safety
3.6.3。安全問題
3.7. Market Dynamics
3.7.市場動態
3.7.1. Market Driver Analysis
3.7.1。市場驅動因素分析
3.7.1.1. Rising Penetration of Omega 3 in Active Pharmaceutical Ingredient Market
3.7.1.1。歐米茄3在活性藥物成分市場的滲透率上升
3.7.1.2. Growing Demand for Dietary Supplements
3.7.1.2。對膳食補充劑日益增長的需求
3.7.2. Market Restraint Analysis
3.7.2。市場約束分析
3.7.2.1. Declining Growth Rate of Fish Production
3.7.2.1。水產品產量增速下降
3.7.3. Industry Challenges
3.7.3。行業挑戰
3.7.3.1. Restricted Supply of Alternative Sources
3.7.3.1。替代來源的有限供應
3.8. Business Environmental Analysis
3.8.營商環境分析
3.9. Market Entry Strategies
3.9.市場進入策略
Chapter 4. Omega 3 Market: Type Estimates & Trend Analysis
第四章歐米茄3市場：類型估計和趨勢分析
Chapter 5. Omega 3 Market: Source Estimates & Trend Analysis
第5章歐米茄3市場：來源估計和趨勢分析
Chapter 6. Omega 3 Market: Application Estimates & Trend Analysis
第6章歐米茄3市場：應用評估和趨勢分析
Chapter 7. Carrageenan Market: Regional Estimates & Trend Analysis
第7章卡拉膠市場：區域估計和趨勢分析
Chapter 8. Competitive Landscape
第八章.競爭格局
Chapter 9. Company Profiles
第9章.公司概況
For more information about this report visit
有關本報告的更多信息，請訪問
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com
高級新聞經理勞拉·伍德
郵箱：Press@researchandMarkets.com
東部夏令時辦公時間請撥打1-917-300-0470
美國/加拿大免費電話：1-800-526-8630
對於格林尼治標準時間辦公時間，請致電+353-1-416-8900
譯文內容由第三人軟體翻譯。